Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status.

Salaffi F, Di Carlo M, Farah S, Atzeni F, Buskila D, Ablin JN, Häuser W, Sarzi-Puttini P.

Rheumatology (Oxford). 2020 Mar 24. pii: keaa061. doi: 10.1093/rheumatology/keaa061. [Epub ahead of print]

PMID:
32206792
2.

The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases.

Talotta R, Atzeni F, Janina Laska M.

APMIS. 2020 Mar 23. doi: 10.1111/apm.13039. [Epub ahead of print] Review.

PMID:
32202683
3.

Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system.

Atzeni F, Masala IF, Cirillo M, Boccassini L, Sorbara S, Alciati A.

Clin Exp Rheumatol. 2020 Jan-Feb;38 Suppl 123(1):94-98. Epub 2020 Feb 4. Review.

4.

Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.

Giorgi V, Bongiovanni S, Atzeni F, Marotto D, Salaffi F, Sarzi-Puttini P.

Clin Exp Rheumatol. 2020 Jan-Feb;38 Suppl 123(1):53-59. Epub 2020 Feb 5.

5.

Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound.

Fiorenza A, Bonitta G, Gerratana E, Marino F, Sarzi-Puttini P, Salaffi F, Atzeni F.

Clin Exp Rheumatol. 2020 Jan-Feb;38 Suppl 123(1):31-39. Epub 2020 Feb 11.

6.

Imaging of diffuse idiopathic skeletal hyperostosis (DISH).

Mader R, Baraliakos X, Eshed I, Novofastovski I, Bieber A, Jorrit-Jan Verlaan JJ, Kiefer D, Pappone N, Atzeni F.

RMD Open. 2020 Feb;6(1). pii: e001151. doi: 10.1136/rmdopen-2019-001151. Erratum in: RMD Open. 2020 Mar;6(1):.

7.

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study.

Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P.

Biologics. 2020 Feb 11;14:13-21. doi: 10.2147/BTT.S209873. eCollection 2020.

8.

CARDIOVASCULAR CONSEQUENCES OF AUTOIMMUNE RHEUMATIC DISEASES.

Atzeni F, Nucera V, Gerratana E, Fiorenza A, Gianturco L, Corda M, Sarzi-Puttini P.

Curr Vasc Pharmacol. 2020 Jan 27. doi: 10.2174/1570161118666200127142936. [Epub ahead of print]

PMID:
31985379
9.

Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet's Syndrome.

Giammello F, Dell'Aera C, Grillo F, Cotroneo M, Casella C, Fazio MC, La Spina P, Francalanza I, Fiorenza A, Toscano A, Atzeni F, Musolino RF.

Clin Neurol Neurosurg. 2020 Apr;191:105680. doi: 10.1016/j.clineuro.2020.105680. Epub 2020 Jan 15.

PMID:
31981998
10.

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.

Cassone G, Manfredi A, Atzeni F, Venerito V, Vacchi C, Picerno V, Furini F, Erre GL, Tomietto P, Fedele AL, Della Casa G, Nucera V, Giannitti C, Salvarani C, Sebastiani M.

J Clin Med. 2020 Jan 19;9(1). pii: E277. doi: 10.3390/jcm9010277.

11.

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

Brito-Zerón P, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnstrom M, Praprotnik S, Sene D, Gerli R, Solans R, Rischmueller M, Mandl T, Suzuki Y, Isenberg D, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura H, Giacomelli R, Devauchelle-Pensec V, Hofauer B, Bombardieri M, Trevisani VFM, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenweider C, Zeher M, Sivils K, Xu B, Bombardieri S, Sandhya P, De Vita S, Minniti A, Sánchez-Guerrero J, Kilic L, van der Heijden E, Park SH, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Rheumatology (Oxford). 2019 Dec 24. pii: kez578. doi: 10.1093/rheumatology/kez578. [Epub ahead of print]

PMID:
31873754
12.

Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review.

Atzeni F, Nucera V, Galloway J, Zoltán S, Nurmohamed M.

Expert Opin Biol Ther. 2020 May;20(5):517-524. doi: 10.1080/14712598.2020.1704727. Epub 2019 Dec 17.

PMID:
31847607
13.

The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors.

Di Carlo M, Muto P, Benfaremo D, Luchetti MM, Atzeni F, Salaffi F.

J Rheumatol. 2019 Dec 1. pii: jrheum.190906. doi: 10.3899/jrheum.190906. [Epub ahead of print]

PMID:
31787602
14.

Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis.

Marino F, Nucera V, Gerratana E, Fiorenza A, Sangari D, Miceli G, Masala IF, Atzeni F.

Pharmacol Res. 2019 Oct 31:104507. doi: 10.1016/j.phrs.2019.104507. [Epub ahead of print] Review. No abstract available.

PMID:
31678639
15.

Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma?

Talotta R, Sarzi-Puttini P, Laska MJ, Atzeni F.

Cytokine Growth Factor Rev. 2019 Oct;49:42-58. doi: 10.1016/j.cytogfr.2019.10.001. Epub 2019 Oct 18. Review.

PMID:
31677967
16.

Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports.

Grossi V, Infantino M, Manfredi M, Basile U, Gulli F, Marino M, Li Gobbi F, Damiani A, Atzeni F, Benucci M.

Clin Chem Lab Med. 2020 Mar 26;58(4):e105-e108. doi: 10.1515/cclm-2019-0950. No abstract available.

PMID:
31665114
17.

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study.

Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, Arrigoni E, Della Casa G, Cerri S, Govoni M, Petricca L, Iannone F, Salvarani C, Sebastiani M.

Intern Med J. 2019 Oct 29. doi: 10.1111/imj.14670. [Epub ahead of print]

PMID:
31661185
18.

Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?

Atzeni F, Svenungsson E, Nurmohamed MT.

Autoimmun Rev. 2019 Dec;18(12):102401. doi: 10.1016/j.autrev.2019.102401. Epub 2019 Oct 23. Review. No abstract available.

PMID:
31655302
19.

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity.

Benucci M, Grossi V, Manfredi M, Damiani A, Infantino M, Moscato P, Cinquanta L, Gremese E, Tolusso B, Petricca L, Fedele AL, Alivernini S, Atzeni F, Minisola G, Verna R.

Ann Lab Med. 2020 Mar;40(2):101-113. doi: 10.3343/alm.2020.40.2.101. Review.

20.

Biosimilars vs originators: Are they the same?

Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z.

Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Review.

PMID:
31639517
21.

Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents.

Rubbert-Roth A, Szabó MZ, Kedves M, Nagy G, Atzeni F, Sarzi-Puttini P.

Autoimmun Rev. 2019 Dec;18(12):102398. doi: 10.1016/j.autrev.2019.102398. Epub 2019 Oct 19. Review.

PMID:
31639514
22.

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature.

La Salvia A, Brizzi MP, Trevisi E, Parisi F, Muratori L, Atzeni F, Di Maio M, Scagliotti GV.

Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4. No abstract available.

PMID:
31583924
23.

Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab.

Atzeni F, Nucera V, Masala IF, Sarzi-Puttini P, Bonitta G.

Pharmacol Res. 2019 Nov;149:104402. doi: 10.1016/j.phrs.2019.104402. Epub 2019 Sep 16. Review.

PMID:
31536783
24.

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W.

Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.

PMID:
31512536
25.

Psoriatic arthritis: From pathogenesis to pharmacologic management.

Talotta R, Atzeni F, Sarzi-Puttini P, Masala IF.

Pharmacol Res. 2019 Oct;148:104394. doi: 10.1016/j.phrs.2019.104394. Epub 2019 Sep 7. Review.

PMID:
31505253
26.

Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.

Guerrini G, Franzetti F, Giacomelli R, Meroni L, Riva A, Scirè CA, Scrivo R, Tavio M, Agostinone A, Airò P, Atzeni F, Bartalesi F, Bazzichi L, Berardicurti O, Cassola G, Castagna A, Castelli F, Cattelan A, Citriniti G, Cristini F, De Rosa F, Fracassi E, Galloway J, La Paglia GMC, Moioli MC, Ripamonti D, Saracino A, Tani C, Tascini C, Tieghi T, Tinelli M, Zabotti A, Sarzi-Puttini P, Galli M.

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):245-256. Epub 2019 Aug 27.

27.

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, Navarini L, Destro Castaniti GM, Maruotti N, Di Scala G, Picciariello L, Caso F, Bongiovanni S, Grembiale RD, Atzeni F, Scarpa R, Perosa F, Emmi G, Cantatore FP, Guggino G, Afeltra A, Ciccia F, Giacomelli R.

Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.

28.

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

Retamozo S, Acar-Denizli N, Rasmussen A, Horváth IF, Baldini C, Priori R, Sandhya P, Hernandez-Molina G, Armagan B, Praprotnik S, Kvarnstrom M, Gerli R, Sebastian A, Solans R, Rischmueller M, Pasoto SG, Valim V, Nordmark G, Kruize A, Nakamura H, Hofauer B, Giacomelli R, Fernandes Moça Trevisani V, Devauchelle-Pensec V, Atzeni F, Gheita TA, Consani-Fernández S, Szántó A, Sivils K, Gattamelata A, Danda D, Kilic L, Bartoloni E, Bombardieri S, Sánchez-Guerrero J, Wahren-Herlenius M, Mariette X, Ramos-Casals M, Brito-Zerón P; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):97-106. Epub 2019 Aug 28.

29.

Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis.

D'Ascenzo F, Salizzoni S, Saglietto A, Cortese M, Latib A, Franzone A, Barbanti M, Nietlispach F, Holy EW, Burriesci G, De Paoli A, Fonio P, Atzeni F, Moretti C, Perl L, D'Amico M, Rinaldi M, Conrotto F.

Eur J Cardiothorac Surg. 2019 Sep 1;56(3):488-494. doi: 10.1093/ejcts/ezz099.

PMID:
31321408
30.

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment.

Atzeni F, Gianturco L, Boccassini L, Sarzi-Puttini P, Bonitta G, Turiel M.

Future Sci OA. 2019 Jun 13;5(6):FSO396. doi: 10.2144/fsoa-2018-0108.

31.

The therapeutic journey of biologic agents: There will be an end?

Atzeni F, Sarzi-Puttini P.

Pharmacol Res. 2019 Sep;147:104340. doi: 10.1016/j.phrs.2019.104340. Epub 2019 Jul 2.

PMID:
31276775
32.

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Caso F, Perosa F, Atzeni F, Cantatore FP, Scarpa R, Ciccia F, Giacomelli R.

Rheumatol Int. 2020 Jan;40(1):107-113. doi: 10.1007/s00296-019-04358-w. Epub 2019 Jul 1.

PMID:
31263993
33.

Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.

Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):500-510. doi: 10.1016/j.berh.2019.02.003. Epub 2019 Feb 27. Review.

PMID:
31174819
34.

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS).

Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, Sengupta R, Atzeni F, Martin KR, Jones GT, Dean LE.

BMC Rheumatol. 2019 May 20;3:19. doi: 10.1186/s41927-019-0066-7. eCollection 2019.

35.

Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.

Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R.

Clin Exp Rheumatol. 2020 Jan-Feb;38(1):19-26. Epub 2019 May 10.

PMID:
31074721
36.

Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study.

Damiani G, Pigatto PDM, Marzano AV, Rizzi M, Santus P, Radovanovic D, Loite U, Torelli L, Petrou S, Sarzi-Puttini P, Atzeni F, Adawi M, Bridgewood C, Bragazzi NL, Watad A, Malerba M.

Clin Rheumatol. 2019 Sep;38(9):2541-2546. doi: 10.1007/s10067-019-04536-y. Epub 2019 Apr 24.

PMID:
31020473
37.

Disentangling geometrical, viscoelastic and hyperelastic effects in force-displacement relationships of folded biological tissues.

Atzeni F, Lanfranconi F, Aegerter CM.

Eur Phys J E Soft Matter. 2019 Apr 18;42(4):47. doi: 10.1140/epje/i2019-11807-x.

PMID:
31011840
38.

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.

Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, Winthrop KL, Galloway JB.

Rheumatology (Oxford). 2019 Oct 1;58(10):1755-1766. doi: 10.1093/rheumatology/kez087.

PMID:
30982883
39.

Systemic rheumatic diseases: From biological agents to small molecules.

Sarzi-Puttini P, Ceribelli A, Marotto D, Batticciotto A, Atzeni F.

Autoimmun Rev. 2019 Jun;18(6):583-592. doi: 10.1016/j.autrev.2018.12.009. Epub 2019 Apr 5. Review.

PMID:
30959214
40.

Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis.

Talotta R, Rigamonti F, Letizia T, Bongiovanni S, Ditto MC, Antivalle M, Santandrea S, Atzeni F, Vago T, Sarzi-Puttini P.

Reumatismo. 2019 Apr 1;71(1):19-23. doi: 10.4081/reumatismo.2019.1129.

41.

Severe bitter taste associated with apremilast.

Damiani G, Bragazzi NL, Grossi E, Petrou S, Radovanovic D, Rizzi M, Atzeni F, Sarzi-Puttini P, Santus P, Pigatto PD, Franchi C.

Dermatol Ther. 2019 May;32(3):e12876. doi: 10.1111/dth.12876. Epub 2019 Mar 26. No abstract available.

PMID:
30882959
42.

Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients.

Rizzi M, Radovanovic D, Airoldi A, Cristiano A, Frassanito F, Gaboardi P, Saad M, Atzeni F, Sarzi-Puttini P, Santus P.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):125-132. Epub 2019 Feb 27. Review.

43.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
44.

Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography.

Casale R, Boccia G, Symeonidou Z, Atzeni F, Batticciotto A, Salaffi F, Sarzi-Puttini P, Brustio PR, Rainoldi A.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):75-80. Epub 2019 Feb 8.

45.

Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study.

Atzeni F, Casale R, Alciati A, Masala IF, Batticciotto A, Talotta R, Gerardi MC, Salaffi F, Sarzi-Puttini P.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):63-69. Epub 2019 Feb 6.

PMID:
30747099
46.

One year in review 2019: fibromyalgia.

Atzeni F, Talotta R, Masala IF, Giacomelli C, Conversano C, Nucera V, Lucchino B, Iannuccelli C, Di Franco M, Bazzichi L.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):3-10. Epub 2019 Feb 6. Review.

47.

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.

Talotta R, Sarzi-Puttini P, Atzeni F.

J Immunol Res. 2019 Jan 6;2019:8567364. doi: 10.1155/2019/8567364. eCollection 2019. Review.

48.

Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes.

Talotta R, Mercurio V, Bongiovanni S, Vittori C, Boccassini L, Rigamonti F, Batticciotto A, Atzeni F, Trabattoni D, Sarzi-Puttini P, Biasin M.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):70-77. Epub 2019 Jan 10.

49.

Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.

Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, D'Angelo S, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Mod Rheumatol. 2019 Nov;29(6):895-902. doi: 10.1080/14397595.2018.1558918. Epub 2019 Jan 22. Erratum in: Mod Rheumatol. 2019 Apr 2;:1.

PMID:
30582388
50.

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts.

Favalli EG, Becciolini A, Caporali R, Todoerti M, Iannone F, Dinoia L, Sebastiani M, Spinella A, Gremese E, Cianci F, Atzeni F, Bandinelli F, Ferraccioli G, Lapadula G; GISEA Study Group.

Autoimmun Rev. 2018 Dec;17(12):1251-1258. doi: 10.1016/j.autrev.2018.07.002. Epub 2018 Oct 16. Review.

PMID:
30339886

Supplemental Content

Loading ...
Support Center